Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone.

Recent observations have shown that the pineal hormone melatonin (MLT) may modulate oestrogen receptor (ER) expression and inhibit breast cancer cell growth. On this basis, we have evaluated the biological and clinical effects of a concomitant MLT therapy in women with metastatic breast cancer who h...

Descripción completa

Detalles Bibliográficos
Autores principales: Lissoni, P., Barni, S., Meregalli, S., Fossati, V., Cazzaniga, M., Esposti, D., Tancini, G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033724/
https://www.ncbi.nlm.nih.gov/pubmed/7710954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033724/
https://www.ncbi.nlm.nih.gov/pubmed/7710954

Ejemplares similares